Westfield Capital Management
COLL icon

Westfield Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Westfield Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-184,461
Closed -$4.08M – 278
2015
Q3 		$4.08M Buy
+184,461
New +$3.34M 0.03% 215

Other funds holding COLL

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Westfield Capital Management's COLL Position: Q4 2015 in Review

Westfield Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2015, closing a stake of 184,461 shares — an estimated $4.08M sold.

Westfield Capital Management first reported a position in COLL in Q3 2015 and held it in 1 quarter. The position peaked at $4.08M in Q3 2015. 60 funds tracked by Wall St. Rank hold COLL as of Q4 2015.

  • Westfield Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2015 after selling out during the quarter.
  • Westfield Capital Management sold 184,461 Collegium Pharmaceutical shares in Q4 2015, an estimated $4.08M.
  • Westfield Capital Management first reported a position in Collegium Pharmaceutical in Q3 2015 and held it in 1 quarter.
  • Westfield Capital Management's Collegium Pharmaceutical position peaked at $4.08M in Q3 2015.
  • 60 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2015.

Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.